Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Albendazole is the active ingredient of these drugs:
Ecuador
Brazil
Singapore
Ecuador
Brazil
Estonia United States
Ecuador
Singapore
Turkey
Estonia Lithuania Turkey
Ecuador
Ecuador
South Africa
Ecuador
Romania
Australia Austria Estonia France Lithuania
Ecuador
Turkey
Ecuador
Ecuador
Ecuador
Lithuania
Brazil
Brazil
Tunisia
South Africa
South Africa
Brazil
Ecuador
Ecuador
Romania
Ecuador
Ecuador
South Africa
Tunisia
Tunisia
Australia Ecuador France Mexico Poland
Cyprus
Brazil
Albendazole is also found within below combination drugs:
ASCARAMEB , LOXCELL NF , OXAL , PARASI-KIT , PARASIPACK , PAZIDOL 1-2 , PROTHELMINT